In conclusion, the present meta-analysis indicates that overexpression of SIRT3 is not related to overall survival in various cancer patients and there exists no correlation between SIRT3 overexpression and other clinicopathological parameters such as lymph node metastasis in total effect analyses. This evidence concerns the gene SIRT3 and metastatic malignant neoplasm in the lymph nodes.